An insight into NIH’s Big Data to Knowledge project

DNAdigest– official supporter of BioData World Congress USA, interviewed Phil Bourne – Associate Director for Data Science at the National Institutes of Health about the Big Data to Knowledge (BD2K) project. What is Big Data to Knowledge (BD2K)? “BD2K is an NIH program across 27 institutes of about 110 million dollars a year. The program focus is on the challenges emerging in data across biosciences, …

TotalBioPharma LIVE with BioSingapore

Q : “How many biotechs are there in Singapore?” A : “There are around 200 biotechs but if you are talking about the successful ones, there are only a handful.” This was one of many candid answers given by the expert panel made up of Singapore’s leading minds in the biopharmaceutical sector at the TotalBioPharma Live in Singapore meetup yesterday, …

Pharma M&A Biomedical in the north

The Northern Factor and Scientific Research

Whilst the news has been dominated by Pfizer and AstraZeneca, there has been a very different story developing in the north of the UK. The Northern Health Science Alliance (NHSA) has brought together eight universities, eight NHS trusts and announced links with foreign companies, from the US and Sweden to develop new products and create ‘an internationally recognized life science …

Literature mining in support of drug discovery

The drug discovery enterprise provides strong drivers for data integration.While attention in this arena has tended to focus on integration of primary data from omics and other large platform technologies contributing to drug discovery and development, the scientific literature remains a major source of information valuable to pharmaceutical enterprises, and therefore tools for mining such data and integrating it with …